Advanced Oncotherapy (FRA:R3I1) Total Liabilities : €107.94 Mil (As of Jun. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Advanced Oncotherapy Total Liabilities?

Advanced Oncotherapy's Total Liabilities for the quarter that ended in Jun. 2022 was €107.94 Mil.

Advanced Oncotherapy's quarterly Total Liabilities declined from Jun. 2021 (€104.58 Mil) to Dec. 2021 (€94.06 Mil) but then increased from Dec. 2021 (€94.06 Mil) to Jun. 2022 (€107.94 Mil).

Advanced Oncotherapy's annual Total Liabilities increased from Dec. 2019 (€80.08 Mil) to Dec. 2020 (€86.34 Mil) and increased from Dec. 2020 (€86.34 Mil) to Dec. 2021 (€94.06 Mil).

Advanced Oncotherapy Total Liabilities Historical Data

The historical data trend for Advanced Oncotherapy's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Total Liabilities Chart

Advanced Oncotherapy Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Liabilities

Get a 7-Day Free Trial

18.96

28.32

80.08

86.34

94.06

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Total Liabilities	Get a 7-Day Free Trial															77.27	86.34	104.58	94.06	107.94

Advanced Oncotherapy Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Advanced Oncotherapy's Total Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18.969	+	(50.115	+	24.972
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	94.06

Total Liabilities	=	Total Assets (A: Dec. 2021 )	-	Total Equity (A: Dec. 2021 )
	=	166.28	-	72.223
	=	94.06

Advanced Oncotherapy's Total Liabilities for the quarter that ended in Jun. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	30.237	+	(52.8	+	24.904
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	107.94

Total Liabilities	=	Total Assets (Q: Jun. 2022 )	-	Total Equity (Q: Jun. 2022 )
	=	178.45	-	70.51
	=	107.94

Advanced Oncotherapy Total Liabilities Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Oncotherapy (FRA:R3I1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (FRA:R3I1) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.

Advanced Oncotherapy (FRA:R3I1) Headlines

No Headlines